http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-PA04009426-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fc6c2e9e63b6561f2f46b1de31f6379
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2003-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d14dc6c612c351e4f94ff4174bd99bbc
publicationDate 2005-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-PA04009426-A
titleOfInvention USEFUL COMPOUNDS IN THE PREPARATION OF CAMPTOTECHINE DERIVATIVES.
abstract Novel compounds are provided having formula (1) and salts thereof, wherein R 1 is hydrogen, an alkyl, aralkyl, hydroxymethyl, carboxymethyl, acyloxymethyl or trialkylsilyl group, or a -CH 2 NR 3 R 4 group where N is a nitrogen bonding atom and where (a) R3 and R4 are independently selected from the groups of hydrogen and alkyl, alkenyl, hydroxyalkyl and alkoxyalkyl; (b) R3 is hydrogen or an alkyl, alkenyl, hydroxyalkyl or alkoxyalkyl group and R4 is -COR5 where R5 is hydrogen or an alkyl, alkenyl, hydroxyalkyl or alkoxyalkyl group; or (c) R3 and R4 taken together with the binding nitrogen atom form a saturated 3- to 7-membered heterocyclic group. These compounds are useful intermediates in a process to prepare camptotecin derivatives including the anti-cancer drug irinotecan.
priorityDate 2002-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74990
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104842
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID243
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22727520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397482
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449831253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449203526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22282751
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6410751
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552902
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423042841
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555086
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484158
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420016488
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481343
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID78607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID312

Total number of triples: 45.